Ajanta Pharma share news, announcements and annual reports
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Ajanta Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2000 on NSE, Jun 2000 on BSE
Last close ₹3,508.80up ₹49.10 (1.42%)BSE ₹3,512.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,459.70.
30 Oct: open ₹3,479.00, high ₹3,619.90, low ₹3,460.50
52-week range of traded prices to 30 Oct 2026
₹2,430.00Low, 30 Oct 2025₹3,796.00High, 18 Aug 2026
- Next results date: the board meets on 30 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹43,846 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.72
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.02
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.71%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 30.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,52,55826.6% delivered
Ajanta Pharma share news and announcements
812 announcements, routine notices left out, newest first. Page 16 of 17.
Apr 2010
8 Apr · Disclosure
Disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Apr · Results
Results of the fourth quarter ended March 31, 2010 along with Audited results for the financial year ended March 31, 2010 will be duly published audited within 60 days. In view of this, the unaudited results for the said quarter ended March 31, 2010 will not be published or furnished to the Stock Exchange.
Jan 2010
18 Jan · Board meeting
Meeting on 29 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
30 Oct · Public Notice - Buy Back of Equity Shares
Board Resolution and Public Notice pursuant to SEBI (Buyback of Securities), Regulation, 1998. The copies of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.30 Oct · Business
Press release dated October 29, 2009 titled "Excellent Peformance by Ajanta Pharma". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.30 Oct · Buy back
Press release which is as follows: The Board in its meeting held on October 29, 2009 approved buyback of company's own shares through stock exchanges for an amount of Rs. 11.36 crs, at a price not exceeding Rs. 101 per share, subject to regulatory approvals, as may be necessary.28 Oct · Meeting
Proceedings-cum-minutes of the Extra-ordinary General meeting held on October 22, 2009 for announcing the results of the Postal Ballot. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Oct · Results
As per the report submitted by the Scrutinizer, Mr. Alwyn Dsouza, Practicing Company Secretary for the Postal Ballot conducted by the company and the result was announced by the Chairman of the Company on October 22, 2009. As per the Scrutinizer's Report total 335 Ballot Forms comprising of 7,98,76,060 votes have been received. The results of the Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Oct · Board meeting
To consider and approve the Unaudited Financial Results for the second quarter and half year ended on September 30, 2009 and consider the proposal for the buy-back of shares.
Sep 2009
14 Sep · Rating
After surveillance, Credit Analysis & Research Limited (CARE) has assigned "PR-1" (pronounced as PR-One) rating for Company's proposed Commercial Paper Programme of Rs. 30 Crores for a maturity not exceeding one year.10 Sep · Meeting
Notice is here by given, pursuant to Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution by Postal Ballot), Rules 2001, for passing the following resolution: Special Resolution for alteration of Articles of Association of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Sep · Updates
Board of Directors has pursuant to Resolution by Circulation under Section 289 of the Companies Act, 1956 on 1st September, 2009 passed a resolution to amend the Articles of Association for insertion of demat clause, dividend clause and buy back shares. The Board has decided to amend the articles by way of Special Resolution through Postal Ballot.
Aug 2009
13 Aug · Change in Designation
There is change in designation of one of our Director Mr. Chandrakant Khetan from Additional Director to Independent Director. The said change is w.e.f. July 9, 2009, i.e. from the date of Annual General Meeting of the Company.11 Aug · Disclosure
Regulation 8A(4) of SEBI (SAST) Regulations, 1997 giving details of shares revoked alongwith the respective dates by the promoters. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Aug · Management
Nikhil Bhatt had joined as a Company Secretary in the organization w.e.f. January 22, 2009 in place of Mr. C Napoleon who had resigned from the organization on January 17, 2009.4 Aug · Management
Mr. Santosh Bhattcherjee, Nominee Director of Industrial Development Bank of India has resigned w.e.f. 30th July, 2009 and in his place Mr. Subal Chandra Saha has been appointed as a Nominee Director w.e.f. 30th July, 2009
Jul 2009
30 Jul · Business
Press release dated July 30, 2009, titled "Ajanta Pharma Net Profit grows 39%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Jul · Board meeting
To consider and approve the Unaudited Financial Results for the first quarter ended on June 30, 2009.16 Jul · Meeting
Minutes of the Annual General Meeting of shareholders of the Company held on July 09, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Jul · Meeting
Notice of the Annual General Meeting of the Shareholders of the Company to be held on July 09, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2009
23 Jun · Dividend
Date of payment of dividend on equity shares would be on or after July 18, 2009, if it is approved by the shareholders at the forthcoming Annual General Meeting.16 Jun · Meeting
Company shall close its Equity Share Transfer Books for a period from July 03, 2009 to July 09, 2009 ( both days inclusive). The Said Book Closure is as per the statutory requirement of the Listing Agreement and also for declaration of dividend. The Board has recommended dividend @ Rs.2.50 per equity share of Rs.10/- each for the year ended March 31, 2009 to be paid to the shareholders if the same is approved by the shareholders in the Annual General Meeting of the company to be held on July 09, 2009.
May 2009
29 May · Management
Mr. Chandrakant Khetan has been appointed as Additional Director of the Company w.e.f. October 20, 2008 and to hold office till ensuing Annual General Meeting pursuant to the provision of Section 260 of the Companies Act, 1956 and Article No. 118 of the Articles of Association of the Company.15 May · Business
Press release dated May 15, 2009 titled "Consistent Growth for Ajanta Pharma; Profit up 20%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 May · Meeting
Board of Directors, at their meeting held on May 15, 2009, the Board of Directors have recommended the dividend @ Rs. 2.50 per share, subject to approval of the shareholders at the ensuing Annual General Meeting to be held on July 09, 2009.6 May · Board meeting
To consider and approve, inter alia, the audited Financial Results for the year ended March 31, 2009 and recommending dividend, if any, on equity shares of the Company for the Financial Year 2008-09.
Apr 2009
28 Apr · Results
Audited Results for the Financial year ended on March 31, 2009 will be published duly audited within 3 months. In view of this, the unaudited results for the said quarter will not be published or furnished to the Stock Exchanges.
Jan 2009
29 Jan · Business
Press release dated January 29, 2009 titled "Ajanta Pharma Q3 Net Profit up 17%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Jan · Board meeting
Meeting on 29 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
23 Oct · Business
Press release dated October 23, 2008, titled "Ajanta Pharma Continues Growth Q2 Net Profit up 54%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Oct · Board meeting
To consider and approve the Unaudited Financial Results for the second quarter and half year ended on September 30, 2008.
Aug 2008
13 Aug · Management
(1) Mr.Vikramaditya Ugra, Nominee Director of EXIM Bank has resigned w.e.f 26th July,2008 and in his place Ms.Manjiri Bhalerao has been appointed w.e.f. 28th July,2008. (2) Mr.Madhukar has resigned w.e.f 31st July,2008.
Jul 2008
30 Jul · Business
Press release dated July 30, 2008, titled "Ajanta Pharma Profit up 37%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jul · Meeting
Proceedings-cum-minutes of the Annual General Meeting of shareholders of the Company held on July 08, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jul · Board meeting
Meeting on 30 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
Jun 2008
18 Jun · Dividend
The date of payment of dividend on equity shares would be on or after July 08, 2008, if it is approved by shareholders at the forthcoming Annual General Meeting.4 Jun · Meeting
Ajanta Pharma Limited had informed the Exchange that the Annual General Meeting will be held on June 27, 2008. The Company has now informed the Exchange that Annual General Meeting is re-scheduled to be held on July 08, 2008. Further the Company shall close its Equity Share Transfer Books for a period from July 01, 2008 to July 08, 2008 (both days inclusive) for the purpose of declaration of dividend.
Apr 2008
30 Apr · Business
Press release dated April 30, 2008, titled "Ajanta Pharma Posts Healthy Results; Consolidated Profit up 49%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.30 Apr · Meeting
Board of Directors of the Company at its meeting held April 30, 2008 have recommended the dividend @ Rs.2.50 per share, subject to the approval of the shareholders at the ensuing Annual General Meeting to be held on June 27, 2008.16 Apr · Board meeting
To consider and approve, inter alia, the audited Financial Results for the year ended March 31, 2008 and recommending dividend, if any, on equity shares of the Company for the Financial Year 2007 -08.
Feb 2008
11 Feb · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
30 Jan · Business
Press release dated January 30, 2008, titled "Ajanta Pharma Profit After Tax up 49%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Jan · Updates
Ajanta Pharma Limited has been conferred with "Quality Excellence Award 2007 - Silver" (in the category of formulation units with annual turnover of more than Rs. 100 crores) by Indian Drug Manufacturer's Association (IDMA). The award is in recognition of company's excellence in quality, production, material management, utility, personnel and safety systems followed at its manufacturing facility at Paithan near Aurangabad
Dec 2007
17 Dec · Business
Press release dated December 15, 2007, titled "Ajanta Pharma brings younger generation for spearheading accelerated growth". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
14 Nov · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
30 Oct · Business
Press release dated October 30, 2007, titled "Ajanta Pharma creates niche ENT Division Profit After Tax up 31% in Q2". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Oct · Board meeting
To consider and approve the Unaudited Financial Results for the second quarter and half year ended on September 30, 2007.5 Oct · Meeting
Proceedings-cum-minutes of the Annual General Meeting held on September 28, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2007
20 Sep · Dividend
The date of payment of dividend on equity shares would be on or after 28th September, 2007, if it is approved by the shareholders at the forthcoming Annual General Meeting13 Sep · Business
Press release dated September 13, 2007, titled "Ajanta Pharma Join Hands with Prollenium Technologies, Canada to launch "Derma Fillers" in India with Exclusive Marketing Rights". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.